2 November 2018 - - US-based life sciences, diagnostics, and applied chemical markets supplier Agilent Technologies Inc. (NYSE: A) has launched the Cary 3500 UV-Vis system, an innovative spectrophotometer designed to help life science, pharma and biopharma research communities simplify their analyses, optimise laboratory productivity, and ultimately help bring new therapeutics to market faster, the company said.

Agilent will showcase the Cary 3500 UV-Vis system at analytica China, being held October 31 November 2, 2018, in Shanghai, China.

Global growth in the development of biological drugs is leading to the evolution of many new biological entities.

Before these NBEs are adapted into therapeutics, laboratories must accurately characterize each new product and continuously monitor the quality of these products throughout the development process.

According to the company, the new system enables laboratories to make substantial gains in efficiency as it can run multiple experiments simultaneously, allowing labs to obtain more results in the same amount of time--and it also extends the opportunity to design experiments in ways that have not been possible before.

The Cary 3500 harnesses the power of a state-of-the-art software platform and a fast and powerful Xenon flash lamp that is redefining UV-Vis spectrophotometry.

Indeed, the system's rapid, accurate, temperature control permits temperature experiments at ramp rates previously thought to be unattainable, providing more reliable and robust measurements.

Agilent Technologies Inc. (NYSE: A) is a leader in life sciences, diagnostics, and applied chemical markets.

With more than 50 years of insight and innovation, Agilent instruments, software, services, solutions, and people provide trusted answers to customers' most challenging questions.

The company generated revenues of USD 4.47bn in fiscal 2017 and employs 14,500 people worldwide.